Topical agents for the treatment of psoriasis, past, present and future

Journal of Cutaneous Medicine and Surgery

Volumn 6, Issue 3 SUPPL., 2002, Pages 8-11

  Tremblay, Jean François ^a   Bissonnette, Robert ^a  

^a NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPSORIASIS AGENT; ASCOMYCIN; BETAMETHASONE VALERATE; CALCIPOTRIOL; CALCITRIOL; CORTICOSTEROID; CYCLOSPORIN; DITHRANOL; ETRETIN; ETRETINATE; MACROLIDE; RAPAMYCIN; SALICYLIC ACID; TACROLIMUS; TAR; TAZAROTENE; VITAMIN D;

CLINICAL TRIAL; CONTACT DERMATITIS; DRUG EFFECT; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; FOLLOW UP; HUMAN; HYPERCALCEMIA; PRIORITY JOURNAL; PSORIASIS; PUVA; SHORT SURVEY; SKIN ATROPHY; TACHYPHYLAXIS;

EID: 0036348609     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1177/12034754020060s303     Document Type: Short Survey

References (51)

1. Fatal iatrogenic Cushing's syndrome
2. Tachyphylaxis to the action of topically applied corticosteroids
3. Failure to demonstrate therapeutic tachyphylaxis to topically applied steroids in patients with psoriasis
4. Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas
5. Intermittent corticosteroid maintenance treatment of psoriasis: A double-blind multicenter trial of augmented betamethasone dipropionate ointment in a pulse dose treatment regimen
6. Are topical corticosteroids useful adjunctive therapy for the treatment of psoriasis with ultraviolet radiation? A review of the literature
7. Combined treatment of psoriasis with a new aromatic retinoid (Tigason) in low dosage orally and triamcinolone acetonide cream topically: A double-blind trial
8. Individualized short-course cyclosporin therapy in psoriasis
9. Betamethasone valerate foam 0.12%: A novel vehicle with enhanced delivery and efficacy
10. Topical tacalcitol treatment for psoriasis
11. Clinical experience with topical calcitriol (1,25-dihydroxyvitamin D3) in psoriasis
12. Topical treatment of psoriatic plaques with 1,25-dihydroxyvitamin D3: A cell biological study
13. Topical calcitriol (1,25-dihydroxyvitamin D3) treatment of psoriasis: An immunohistological evaluation
14. Topical calcipotriol in the treatment of intertriginous psoriasis
15. The effects of UVB plus calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis
16. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris
17. A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis
18. Long-term outcome of severe chronic plaque psoriasis following treatment with high-dose topical calcipotriol
19. Comparative effects of calcipotriol solution (50 micrograms/ml) and betamethasone 17-valerate solution (1 mg/ml) in the treatment of scalp psoriasis
20. Calcipotriol ointment in nail psoriasis; a controlled double-blind comparison with betamethasone dipropionate and salicylic acid
21. Pustular psoriasis of the nails: Treatment and long-term follow-up of 46 patients
22. Calcipotriol improves the response of psoriasis to PUV A
23. The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis
24. Calcipotriol improves the efficacy of cyclosporine in the treatment of psoriasis vulgaris
25. Combination of topical calcipotriol (MC 903) and UVB radiation for psoriasis vulgaris
26. No additional effect of calcipotriol ointment on low-dose narrow-band UVB phototherapy in psoriasis
27. Interactions between Calcipotriene and ultraviolet light
28. Calcipotriol ointment and cream or their vehicles applied immediately before irradiation inhibit ultraviolet B-induced erythema
29. Treatment of psoriasis with a new combination of calcipotriol and betamethasone dipropionate: A flow cytometric study
30. Tazarotene
31. Molecular mechanisms of tazarotene action in psoriasis
32. Tazarotene gel, a new retinoid, for topical therapy of psoriasis: Vehicle-controlled study of safety, efficacy, and duration of therapeutic effect
33. The safety and efficacy of tazarotene gel, a topical acetylenic retinoid, in the treatment of psoriasis
34. Short contact tazarotene therapy for psoriasis
35. Tazarotene plus UVB phototherapy in the treatment of psoriasis
36. Combination phototherapy of psoriasis with narrow-band UVB irradiation and topical tazarotene gel
37. Interactions between tazarotene and ultraviolet light
38. The effect of triethanolamine application on anthralin-induced inflammation and therapeutic effect in psoriasis
39. Dithranol embedded in crystalline monoglycerides combined with phototherapy (UVB): A new approach in the treatment of psoriasis
40. Coal tar, pine tar and sulfonated shale oil preparations: Comparative activity, efficacy and safety
41. Dermal uptake of polycyclic aromatic hydrocarbons after hairwash with coal-tar shampoo
42. Cancer in patients treated with coal tar: A long-term follow up study
43. Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study
44. Skin carcinoma in patients with psoriasis treated with topical tar and artificial ultraviolet radiation
45. Topical tacrolimus is not effective in chronic plaque psoriasis. A pilot study
46. Tacrolimus ointment improves psoriasis in a microplaque assay
47. Topical tacrolimus is effective for facial lesions of psoriasis
48. Topical application of mycophenolate mofetil in plaque-type psoriasis
49. Lack of efficacy of topical mycophenolic acid in psoriasis vulgaris
50. Management of psoriasis vulgaris with methotrexate 0.25% in a hydrophilic gel: A placebocontrolled, double-blind study
51. Protoporphyrin IX fluorescence photobleaching during ALA-mediated photodynamic therapy of UVB-induced tumors in hairless mouse skin